Latest filing published 04 Sept 2026 for Axogen, Inc., €150k.
Filing timeline
BuySaleInsider track record
Joseph A. Tyndall: trading record in brief
All filings by Joseph A. Tyndall on record concern Axogen, Inc. Between 6 June 2024 and 2 September 2026, the trades on record add up to 15 filings.
No open-market purchase appears, only 7 sales worth €1.3M. Other entries cover 1 share grant and 7 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 4 September 2026, the filings show an open-market sale worth €150k in Axogen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph A. Tyndall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ US$49.6970.0067% mcap39.9% of flowCommon StockSEC:0000805928-26-000101:0
- 14,150 sharesCommon StockSEC:0000805928-26-000077:0
- 14,248 shares@ US$7.0422.9% of flowCommon StockSEC:0000805928-25-000166:0
- 7,586 shares@ US$6.3011.1% of flowCommon StockSEC:0000805928-25-000080:0
- 12,850 shares@ US$6.3019.1% of flowCommon StockSEC:0000805928-25-000072:0
- 2,525 shares@ US$11.637.0% of flowCommon StockSEC:0000805928-25-000070:0
- 11,904 shares0Common StockSEC:0000805928-24-000116:0
- 10,653 sharesCommon StockSEC:0000805928-24-000091:0
8 of 8 declarations
